NCT07360314 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07360314
Title	Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	EMD Serono Research & Development Institute, Inc.
Indications	head and neck squamous cell carcinoma triple-receptor negative breast cancer stomach cancer lung non-small cell carcinoma pancreatic ductal adenocarcinoma Advanced Solid Tumor ovary epithelial cancer lung non-squamous non-small cell carcinoma
Therapies	M7437
Age Groups:	adult \| senior
Covered Countries	USA \| ESP \| CAN

NCT07360314
Clinical Trial Detail